National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings, 43393-43394 [2017-19592]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 178 / Friday, September 15, 2017 / Notices
Potential Commercial Applications:
• Therapeutics for hypertension
• Therapeutics for anxiety disorders
• Therapeutics for sleep disorders
Development Stage:
• In vivo data available
Inventors: George Kunos and
Alexandros Makriyannis (both of
NIAAA)
Intellectual Property: HHS Reference
No. E–211–2006/0–US–06.
• U.S. Patent 8,293,724 filed April 6,
2010, issued October 23, 2012.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@nih.gov.
Collaborative Research Opportunity:
The National Institute of Environmental
Health Sciences seeks statements of
capability or interest from parties
interested in collaborative research to
further develop and evaluate, please
contact Peg Koelble, Office of
Technology Transfer, National Heart,
Lung and Blood Institute, koelblep@
nhlbi.nih.gov, 301–594–4095.
Dated: September 7, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
[FR Doc. 2017–19590 Filed 9–14–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Chris Kornak, 240–627–3705, chris.
kornak@nih.gov. Licensing information
and copies of the U.S. patent
applications listed below may be
obtained by communicating with the
indicated licensing contact at the
Technology Transfer and Intellectual
Property Office (TTIPO), 5601 Fishers
Lane, Suite 6D, MSC 9804, Rockville,
mstockstill on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:07 Sep 14, 2017
Jkt 241001
43393
No. PCT/US2017/021573 filed on 03/09/
2017.
Licensing Contact: Chris Kornak, 240–
627–3705, chris.kornak@nih.gov.
Collaborative Research Opportunity:
The Technology Transfer and
Intellectual Property Office (TTIPO) is
seeking parties interested in
Recombinant HIV-1 Envelope Proteins
collaborative research to further develop
and Their Use
the technology. In particular, NIAID is
Description of Technology: Millions of interested in partnerships utilizing
vector vaccine platforms for expressing
people are infected with HIV-1
these immunogens.
worldwide. In the U.S., there are about
However, NIAID is willing to discuss
30,000 new cases of HIV infection
other applications of this technology.
reported annually. Currently, there are
For collaboration opportunities, please
effective, anti-retroviral therapeutics
contact Chris Kornak, 240–627–3705,
available to treat or prevent HIV
chris.kornak@nih.gov.
infection. However, available antiretroviral therapeutics require life-long
Dated: September 7, 2017.
administration.
Suzanne Frisbie,
During infection, proteases of the host Deputy Director, Technology Transfer and
cell cleave gp160 into gp120 and gp41.
Intellectual Property Office, National Institute
Gp41 is an integral membrane protein,
of Allergy and Infectious Diseases.
while gp120 protrudes from the mature
[FR Doc. 2017–19591 Filed 9–14–17; 8:45 am]
virus. Together gp120 and gp41
BILLING CODE 4140–01–P
aggregate as trimers that make up the
HIV-1 envelope (‘‘Env’’) spike, which is
a target for neutralizing antibodies.
DEPARTMENT OF HEALTH AND
NIAID researchers have constructed a HUMAN SERVICES
recombinant HIV-1 trimer immunogen.
National Institutes of Health
In particular, the recombinant gp120
protein in the trimer is stabilized in a
closed conformation, preventing it from National Institute on Deafness and
Other Communication Disorders;
binding to CD4. The advantage of the
Notice of Closed Meetings
closed conformation is that it can
stabilize the epitopes that bind to
Pursuant to section 10(d) of the
broadly neutralizing antibodies,
Federal Advisory Committee Act, as
minimize the binding of gp120 with
amended, notice is hereby given of the
weakly or non-neutralizing antibodies,
following meetings.
and prevent conformational changes
The meetings will be closed to the
induced by CD4 as well as immunogen
public in accordance with the
sequestration by CD4 in vivo. Research
provisions set forth in sections
has also indicated that recombinant Env 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
ectodomain trimers can induce higher
as amended. The grant applications and
neutralizing antibody titers than wild
the discussions could disclose
type Env trimers in animal models.
confidential trade secrets or commercial
This technology is available for
property such as patentable material,
licensing for commercial development
and personal information concerning
in accordance with 35 U.S.C. 209 and 37 individuals associated with the grant
CFR part 404, as well as for further
applications, the disclosure of which
development and evaluation under a
would constitute a clearly unwarranted
research collaboration.
invasion of personal privacy.
Potential Commercial Applications:
Name of Committee: National Institute on
• HIV-1 immunogen
Deafness and Other Communication
• New methods for isolating broadly
Disorders Special Emphasis Panel; Chemical
neutralizing antibodies
Senses Fellowship Review.
Competitive Advantages:
Date: October 11, 2017.
• A new strategy in inducing immune
Time: 12:30 p.m. to 3:00 p.m.
response against HIV-1
Agenda: To review and evaluate grant
applications.
Development Stage:
Place: National Institutes of Health.
• Pre-Clinical; Proof-of-concept
Neuroscience Center, 6001 Executive
studies in nonhuman primate
Boulevard, Rockville, MD 20852 (Telephone
models
Conference Call).
Inventors:
Contact Person: Sheo Singh, Ph.D.,
Paolo Lusso, NIAID, NIH
Scientific Review Officer, Scientific Review
Peng Zhang, NIAID, NIH
Branch, Division of Extramural Activities,
Publications: Pending.
6001 Executive Blvd., Room 8351, Bethesda,
Intellectual Property: HHS Reference
MD 20892, 301–496–8683, singhs@
No. E–102–2016/0—PCT Application
nidcd.nih.gov.
MD 20892, tel: 301–496–2644, fax: 240–
627–3117. A signed Confidential
Disclosure Agreement will be required
to receive copies of unpublished patent
applications.
SUPPLEMENTARY INFORMATION:
Technology description follows.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
E:\FR\FM\15SEN1.SGM
15SEN1
43394
Federal Register / Vol. 82, No. 178 / Friday, September 15, 2017 / Notices
mstockstill on DSK30JT082PROD with NOTICES
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Hearing
and Balance Fellowships Review.
Date: October 16, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD
20892, 301–496–8683, yangshi@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; VSL
Fellowship Review.
Date: October 18, 2017.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Sheo Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
6001 Executive Blvd., Room 8351, Bethesda,
MD 20892, 301–496–8683, singhs@
nidcd.nih.gov.
Name of Committee: Communication
Disorders Review Committee.
Date: October 19, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute on
Deafness and other Communication
Disorders/NIH, 6001 Executive Blvd., MSC
9670, Bethesda, MD 20892–8401, 301–496–
8683 el6r@nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; P50
Review.
Date: October 26, 2017.
Time: 11:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Kausik Ray, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health,
Rockville, MD 20850, 301–402–3587,
rayk@nidcd.nih.gov.
request, including your address to:
GarciaA@od.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Special
Volunteer and Guest Researcher
Assignment form—Reinstatement
without Change of OMB #0925–0177,
Office of Intramural Research (OIR),
Office of the Director (OD), National
Institutes of Health (NIH).
Need and Use of Information
Collection: Form Number: NIH–590 is a
single form completed by an NIH
official for each Guest Researcher or
Special Volunteer prior to his/her
arrival at NIH. The information on the
form is necessary for the approving
official to reach a decision on whether
to allow a Guest Researcher to use NIH
facilities, or whether to accept volunteer
services offered by a Special Volunteer.
If the original assignment is extended,
another form notating the extension is
completed to update the file. In
addition, each Special Volunteer and
Guest Researcher reads and signs an
NIH Agreement.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
527.
SUPPLEMENTARY INFORMATION:
Dated: September 8, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–19592 Filed 9–14–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Special Volunteer and Guest
Researcher Assignment (Office of
Intramural Research, Office of the
Director)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, for opportunity
for public comment on proposed data
collection projects, the Office of
Intramural Research (OIR), Office of the
Director (OD), National Institutes of
Health (NIH), will publish periodic
summaries of proposed projects to be
submitted to the Office of Management
and Budget (OMB) for review and
approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Arlyn Garcia-Perez,
Assistant Director, Office of Intramural
Research, Office of the Director,
National Institutes of Health, 1 Center
Drive MSC 0140, Building 1, Room 160,
MSC–0140, Bethesda, Maryland, 20892
or call non-toll-free number (301) 496–
1921 or (301) 496–1381 or Email your
SUMMARY:
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Type of respondents
Special Volunteer and Guest Researcher Assignment.
Special Volunteers and Guest researchers.
VerDate Sep<11>2014
17:07 Sep 14, 2017
Jkt 241001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
2,870
E:\FR\FM\15SEN1.SGM
1
15SEN1
Average
burden per
response
(in hours)
6/60
Total annual
hour burden
hours
287
]]>Agencies
[Federal Register Volume 82, Number 178 (Friday, September 15, 2017)]
[Notices]
[Pages 43393-43394]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19592]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; Chemical Senses
Fellowship Review.
Date: October 11, 2017.
Time: 12:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health. Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Sheo Singh, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, 6001
Executive Blvd., Room 8351, Bethesda, MD 20892, 301-496-8683,
singhs@nidcd.nih.gov.
[[Page 43394]]
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; Hearing and Balance
Fellowships Review.
Date: October 16, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Shiguang Yang, DVM, Ph.D., Scientific Review
Officer, Division of Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD 20892, 301-496-8683,
yangshi@nidcd.nih.gov.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; VSL Fellowship
Review.
Date: October 18, 2017.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Sheo Singh, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, 6001
Executive Blvd., Room 8351, Bethesda, MD 20892, 301-496-8683,
singhs@nidcd.nih.gov.
Name of Committee: Communication Disorders Review Committee.
Date: October 19, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Eliane Lazar-Wesley, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute on
Deafness and other Communication Disorders/NIH, 6001 Executive
Blvd., MSC 9670, Bethesda, MD 20892-8401, 301-496-8683 el6r@nih.gov.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; P50 Review.
Date: October 26, 2017.
Time: 11:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Kausik Ray, Ph.D., Scientific Review Officer,
National Institute on Deafness and Other Communication Disorders,
National Institutes of Health, Rockville, MD 20850, 301-402-3587,
rayk@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.173,
Biological Research Related to Deafness and Communicative Disorders,
National Institutes of Health, HHS)
Dated: September 8, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-19592 Filed 9-14-17; 8:45 am]
BILLING CODE 4140-01-P
